Phase 3 trials needed to determine efficacy of UBI's vaccine: experts
06/28/2021 05:13 PM
Experts in Taiwan said Monday that the results of the clinical trials conducted so far by United Biomedical Inc. (UBI) for its COVID-19 vaccine candidate have shown inconclusive results regarding its efficacy and that it requires further trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Lafayette scandal's Kuo Li-heng dies at 73
07/10/2025 10:13 PM - Culture
National Cultural Award presented to 3 masters in various fields
07/10/2025 09:31 PM - Politics
No plan to greenlight aid for Taipower: KMT Chair
07/10/2025 09:24 PM - Society
Power restored for 94% of homes hit by typhoon-caused record damage
07/10/2025 07:55 PM - Politics
Referendum, 26 recall votes could cost up to NT$1.62 billion: CEC
07/10/2025 07:42 PM